Interprofessional Team Diabetes Case Study

1. C J Diabetes. Canadian Clinical Practice Guidelines. S1-S16. 8-1-2013. Ref Type: Online Source

2. Ohinmaa A, Jacobs P, Simpson S, Johnson JA. The projection prevalence and cost of diabetes in Canada: 2000 to 2016. Can J Diabetes. 2004;28:116–23.

3. Skyler JS. Diabetes mellitus: pathogenesis and treatment strategies. J Med Chem. 2004;47:4113–7. doi: 10.1021/jm0306273.[PubMed][Cross Ref]

4. Skyler JS. The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system. Diabetes Technol Ther. 2000;2(Suppl 1):S7–12. doi: 10.1089/15209150050214069.[PubMed][Cross Ref]

5. UK Prospective Diabetes Study Group High blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;3:977–86.[PMC free article][PubMed]

6. UKPDS Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53. doi: 10.1016/S0140-6736(98)07019-6.[PubMed][Cross Ref]

7. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med. 1997;127:788–95. doi: 10.7326/0003-4819-127-9-199711010-00003.[PubMed][Cross Ref]

8. Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns. 2004;52:97–105. doi: 10.1016/S0738-3991(03)00016-8.[PubMed][Cross Ref]

9. Gary TL, Genkinger JM, Guallar E, Peyrot M, Brancati FL. Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ. 2003;29:488–501. doi: 10.1177/014572170302900313.[PubMed][Cross Ref]

10. Norris SL, Nichols PJ, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22:15–38. doi: 10.1016/S0749-3797(02)00423-3.[PubMed][Cross Ref]

11. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24:561–87. doi: 10.2337/diacare.24.3.561.[PubMed][Cross Ref]

12. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159–71. doi: 10.2337/diacare.25.7.1159.[PubMed][Cross Ref]

13. Siminerio LM, Drab SR, Gabbay RA, Gold K, McLaughlin S, Piatt GA, et al. Diabetes educators: implementing the chronic care model. Diabetes Educ. 2007;34:451–60.[PubMed]

14. Canadian Diabetes Association. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2008.

15. Leiter LA, Berard L, Bowering CK, Cheng AY, Dawson KG, Ekoe JM, et al. Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes. 2013;37:82–9. doi: 10.1016/j.jcjd.2013.02.055.[PubMed][Cross Ref]

16. Padgett D, Mumford E, Hynes M, Carter R. Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus. J Clin Epidemiol. 1988;41:1007–30. doi: 10.1016/0895-4356(88)90040-6.[PubMed][Cross Ref]

17. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics. 1998;101:497–504.[PubMed]

18. Diabetes Complication Prevention Cooperative. Adult gap analysis for southern Ontario 2001. 2001. Toronto, Canada. Ref Type: Report

19. Shah BR, Booth GL. Predictors and effectiveness of diabetes self-management education in clinical practice. Patient Educ Couns. 2009;74:19–22. doi: 10.1016/j.pec.2008.08.005.[PubMed][Cross Ref]

20. Gucciardi E, Chan VWS, Chuen B, Fortugno M, Horodezny S, Swartzack S. Patient Factors and Perceived Barriers in Attending Diabetes Education Programs. Can J Diabetes. 2012;36:214–7. doi: 10.1016/j.jcjd.2012.07.009.[Cross Ref]

21. Gucciardi E, Horodezny S, Swartzack S, Khan S, Chan VWS, Fortugno M. Primary care physician referral patterns to diabetes education programs in Southern Ontario. Can J Diabetes. 2011;35:262–8. doi: 10.1016/S1499-2671(11)53009-6.[Cross Ref]

22. Bolsin S. Quality and safety in healthcare - a challenge accepted. Anaesthesia. 2014;69:1051–2. doi: 10.1111/anae.12819.[PubMed][Cross Ref]

23. Nancarrrow S. Six principles to enhance health workforce flexibility. Hum Resour Health. 2015;13:1–12. doi: 10.1186/1478-4491-13-9.[PMC free article][PubMed][Cross Ref]

24. Team DT. Cost-effectiveness of magnetic resonance imaging of the knee for patients presenting in primary care. Br J Gen Pract. 2008;58. [PMC free article][PubMed]

25. Sharma S, Ward E, Burns C, Theodoros D, Russell T. Training the allied health assistant for the telerehabilitation assessment of dysphagia. J TelemedTelecare. 2012;18:287–91.[PubMed]

26. Rogers A, Flowers J, Pencheon D. Improving access needs a whole systems approach. And will be important in averting crises in the millennium winter. BMJ. 1999;319:866–7. doi: 10.1136/bmj.319.7214.866.[PMC free article][PubMed][Cross Ref]


Brief Summary:

The overall goal of this randomized controlled trial is to test the efficacy of DM I-TEAM (Diabetes Interprofessional Team to Enhance Adherence to Medical Care) to reduce emergency department (ED) visits and hospitalizations over 12 months in older African Americans (AAs) with diabetes mellitus (DM). DM I-TEAM is a multidisciplinary behavioral intervention that comprises a community health worker (CHW), the participant's primary care physician (PCP), a diabetes nurse educator, and a clinical geriatric pharmacist. In DM I-TEAM, the CHW conducts in-home sessions to: (1) provide diabetes education, (2) facilitate adherence to diabetes self-management behaviors (e.g., medication adherence glucose monitoring, diet, exercise); and (3) build trust between patients and their primary care team. This is accomplished by: (1) using culturally relevant diabetes educational materials; (2) facilitating telehealth visits with the participant's PCP and the diabetes nurse educator via JeffConnect; and (3) having the study pharmacist review participants' medication regimens to identify potentially inappropriate medications, simplify medication regimens if possible, and to reduce medication side effects.

DiabetesBehavioral: DM I-TEAM

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment :200 participants
Intervention Model:Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title:Diabetes Interprofessional Team to Enhance Adherence to Medical Care
Actual Study Start Date :January 1, 2017
Estimated Primary Completion Date :December 31, 2020
Estimated Study Completion Date :December 31, 2020

One thought on “Interprofessional Team Diabetes Case Study

Leave a Reply

Your email address will not be published. Required fields are marked *